跳至主要内容
临床试验/PACTR202205801626909
PACTR202205801626909招募中2 期

Randomized, Placebo-Controlled Pilot Study of Origanum majorana Tea on Oxidant/Antioxidant Stress Biomarkers in Parkinson Idiopathic disorder North-African Patients Volunteers

Metabolic Biophysics Applied Pharmacology Laboratory0 个研究点目标入组 60 人开始时间: 2022年5月7日最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
All

入选标准

  • .Age of 40–80 years old
  • .Diagnosis of PD MDS criteria 2015
  • .Hoehn and Yahr stage less than 4
  • .Treatment with dose and regimen unchanged for at least 12 weeks prior to screening
  • .No nutritional supplements intake

排除标准

  • The absence during the second visit (ie; Day31 of the study)
  • The non-consumption of the Omt or the placebo tea at least one time.
  • Patients had a history of cardiovascular disease, diabetes, renal dysfunction, asthma, food allergies, liver or major gastrointestinal problems or hypertension.

研究者

发起方
Metabolic Biophysics Applied Pharmacology Laboratory

相似试验